WT1 and Nephroblastoma: With the increasing accessibility of human DNA sequencing and genomic screening, it will be possible to detect germline changes in the WT1 gene associated with an increased risk of developing Wilms tumor, as recommended by The American College of Medical Genetics and Genomics.